8-K//Current report
Seres Therapeutics, Inc. 8-K
Accession 0001193125-25-080185
$MCRBCIK 0001609809operating
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:13 PM ET
Size
294.5 KB
Accession
0001193125-25-080185
Documents
- 8-Kd935169d8k.htmPrimary
8-K
- EX-10.1d935169dex101.htm
EX-10.1
- EX-101.SCHmcrb-20250410.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABmcrb-20250410_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREmcrb-20250410_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-080185-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd935169d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001609809
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:13 PM ET
- Size
- 294.5 KB